Abstract
The discovery and subsequent characterization of endothelial precursor cells (EPCs) has stimulated interest in their potential use in older persons. Understanding the mechanisms that underlie EPC availability and function has important clinical implications for this age group. In this review, we discuss aspects of EPCs that are relevant to their role in angiogenesis and cardiovascular disease. We then review the limited data on features of EPCs that are known to be altered in aging and might better define their clinical utility in older persons.
Similar content being viewed by others
References
American Heart Association (2007). Older Americans and cardiovascular disease—Statistics.
Barbagallo, M., Resnick, L. M., Dominguez, L. J., & Licata, G. (1997). Diabetes mellitus, hypertension and ageing: The ionic hypothesis of ageing and cardiovascular-metabolic diseases. Diabetes & Metabolism, 23(4), 281–294.
Droge, W. (2002). Free radicals in the physiological control of cell function. Physiological Reviews, 82(1), 47–95.
Bilato, C., & Crow, M. T. (1996). Atherosclerosis and the vascular biology of aging. Aging (Milano), 8(4), 221–234.
Aguirre, F. V., McMahon, R. P., Mueller, H., Kleiman, N. S., Kern, M. J., Desvigne-Nickens, P., et al. (1994). Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators. Circulation, 90(1), 78–86.
Reed, M. J., & Edelberg, J. M. (2004). Impaired angiogenesis in the aged. Science of Aging Knowledge Environment, 2004(7), pe7.
Edelberg, J. M., & Reed, M. J. (2003). Aging and angiogenesis. Frontiers in Bioscience, 8, s1199–s1209.
Sadoun, E., & Reed, M. J. (2003). Impaired angiogenesis in aging is associated with alterations in vessel density, matrix composition, inflammatory response, and growth factor expression. Journal of Histochemistry and Cytochemistry, 51(9), 1119–1130.
Urbich, C., & Dimmeler, S. (2004). Endothelial progenitor cells: Characterization and role in vascular biology. Circulation Research, 95(4), 343–353.
Barber, C. L., & Iruela-Arispe, M. L. (2006). The ever-elusive endothelial progenitor cell: Identities, functions and clinical implications. Pediatric Research, 59(4 Pt 2), 26R–32R.
Sabin, F. R. (2002). Preliminary note on the differentiation of angioblasts and the method by which they produce blood-vessels, blood-plasma and red blood-cells as seen in the living chick. 1917. Journal of Hematotherapy & Stem Cell Research, 11(1), 5–7.
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., et al. (1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275(5302), 964–967.
Shi, Q., Rafii, S., Wu, M. H., Wijelath, E. S., Yu, C., Ishida, A., et al. (1998). Evidence for circulating bone marrow-derived endothelial cells. Blood, 92(2), 362–367.
Lyden, D., Young, A. Z., Zagzag, D., Yan, W., Gerald, W., O'Reilly, R., et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature, 401(6754), 670–677.
Peichev, M., Naiyer, A. J., Pereira, D., Zhu, Z., Lane, W. J., Williams, M., et al. (2000). Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 95(3), 952–958.
Schmeisser, A., Garlichs, C. D., Zhang, H., Eskafi, S., Graffy, C., Ludwig, J., et al. (2001). Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovascular Research, 49(3), 671–680.
Urbich, C., Heeschen, C., Aicher, A., Dernbach, E., Zeiher, A. M., & Dimmeler, S. (2003). Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation, 108(20), 2511–2516.
Rehman, J., Li, J., Orschell, C. M., & March, K. L. (2003). Peripheral blood “endothelial progenitor cells” are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107(8), 1164–1169.
Hillebrands, J. L., Klatter, F. A., van Dijk, W. D., & Rozing, J. (2002). Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Natural Medicines, 8(3), 194–195.
Ingram, D. A., Mead, L. E., Moore, D. B., Woodard, W., Fenoglio, A., & Yoder, M. C. (2005). Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood, 105(7), 2783–2786.
Zengin, E., Chalajour, F., Gehling, U. M., Ito, W. D., Treede, H., Lauke, H., et al. (2006). Vascular wall resident progenitor cells: A source for postnatal vasculogenesis. Development, 133(8), 1543–1551.
Reyes, M., Dudek, A., Jahagirdar, B., Koodie, L., Marker, P. H., & Verfaillie, C. M. (2002). Origin of endothelial progenitors in human postnatal bone marrow. Journal of Clinical Investigation, 109(3), 337–346.
Planat-Benard, V., Silvestre, J. S., Cousin, B., Andre, M., Nibbelink, M., Tamarat, R., et al. (2004). Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation, 109(5), 656–663.
Urbich, C., & Dimmeler, S. (2004). Endothelial progenitor cells functional characterization. Trends in Cardiovascular Medicine, 14(8), 318–322.
Beltrami, A. P., Barlucchi, L., Torella, D., Baker, M., Limana, F., Chimenti, S., et al. (2003). Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell, 114(6), 763–776.
Wurmser, A. E., Nakashima, K., Summers, R. G., Toni, N., D'Amour, K. A., Lie, D. C., et al. (2004). Cell fusion-independent differentiation of neural stem cells to the endothelial lineage. Nature, 430(6997), 350–356.
Aicher, A., Rentsch, M., Sasaki, K., Ellwart, J. W., Fandrich, F., Siebert, R., et al. (2007). Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circulation Research, 100(4), 581–589.
Askari, A. T., Unzek, S., Popovic, Z. B., Goldman, C. K., Forudi, F., Kiedrowski, M., et al. (2003). Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet, 362(9385), 697–703.
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Natural Medicines, 7(4), 430–436.
Laing, A. J., Dillon, J. P., Condon, E. T., Street, J. T., Wang, J. H., McGuinness, A. J., et al. (2007). Mobilization of endothelial precursor cells: Systemic vascular response to musculoskeletal trauma. Journal of Orthoptera Research, 25(1), 44–50.
Soligo, D., Schiro, R., Luksch, R., Manara, G., Quirici, N., Parravicini, C., et al. (1990). Expression of integrins in human bone marrow. British Journal of Haematology, 76(3), 323–332.
Chavakis, E., Aicher, A., Heeschen, C., Sasaki, K., Kaiser, R., El Makhfi, N., et al. (2005). Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. Journal of Experimental Medicine, 201(1), 63–72.
Wu, Y., Ip, J. E., Huang, J., Zhang, L., Matsushita, K., Liew, C. C., et al. (2006). Essential role of ICAM-1/CD18 in mediating EPC recruitment, angiogenesis, and repair to the infarcted myocardium. Circulation Research, 99(3), 315–322.
Qin, G., Ii, M., Silver, M., Wecker, A., Bord, E., Ma, H., et al. (2006). Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization. Journal of Experimental Medicine, 203(1), 153–163.
Lee, S. H., Wolf, P. L., Escudero, R., Deutsch, R., Jamieson, S. W., & Thistlethwaite, P. A. (2000). Early expression of angiogenesis factors in acute myocardial ischemia and infarction. New England Journal of Medicine, 342(9), 626–633.
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., et al. (2001). Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Natural Medicines, 7(11), 1194–1201.
Ling, M. T., Lau, T. C., Zhou, C., Chua, C. W., Kwok, W. K., Wang, Q., et al. (2005). Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis, 26(10), 1668–1676.
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827.
Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., et al. (2002). Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell, 109(5), 625–637.
Yamaguchi, J., Kusano, K. F., Masuo, O., Kawamoto, A., Silver, M., Murasawa, S., et al. (2003). Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation, 107(9), 1322–1328.
Ceradini, D. J., & Gurtner, G. C. (2005). Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends in Cardiovascular Medicine, 15(2), 57–63.
Vajkoczy, P., Blum, S., Lamparter, M., Mailhammer, R., Erber, R., Engelhardt, B., et al. (2003). Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. Journal of Experimental Medicine, 197(12), 1755–1765.
Tamura, M., Unno, K., Yonezawa, S., Hattori, K., Nakashima, E., Tsukada, H., et al. (2004). In vivo trafficking of endothelial progenitor cells their possible involvement in the tumor neovascularization. Life Science, 75(5), 575–584.
Urbich, C., Heeschen, C., Aicher, A., Sasaki, K., Bruhl, T., Farhadi, M. R., et al. (2005). Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Natural Medicines, 11(2), 206–213.
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., et al. (2000). Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biology, 2(10), 737–744.
Turpeenniemi-Hujanen, T. (2005). Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie, 87(3–4), 287–297.
Ballard, V. L., Sharma, A., Duignan, I., Holm, J. M., Chin, A., Choi, R., et al. (2006). Vascular tenascin-C regulates cardiac endothelial phenotype and neovascularization. FASEB Journal, 20(6), 717–719.
Lai, S. R., Phipps, S. M., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2005). Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems. Frontiers in Bioscience, 10, 1779–1796.
Park, Y., & Gerson, S. L. (2005). DNA repair defects in stem cell function and aging. Annual Review of Medicine, 56, 495–508.
Fleisig, H. B., & Wong, J. M. (2007). Telomerase as a clinical target: Current strategies and potential applications. Experimental Gerontology, 42(1–2), 102–112.
Resnitzky, P., Segal, M., Barak, Y., & Dassa, C. (1987). Granulopoiesis in aged people: Inverse correlation between bone marrow cellularity and myeloid progenitor cell numbers. Gerontology, 33(2), 109–114.
Muschler, G. F., Nitto, H., Boehm, C. A., & Easley, K. A. (2001). Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. Journal of Orthoptera Research, 19(1), 117–125.
Shaffer, R. G., Greene, S., Arshi, A., Supple, G., Bantly, A., Moore, J. S., et al. (2006). Flow cytometric measurement of circulating endothelial cells: the effect of age and peripheral arterial disease on baseline levels of mature and progenitor populations. Cytometry B Clin Cytom, 70(2), 56–62.
Scheubel, R. J., Zorn, H., Silber, R. E., Kuss, O., Morawietz, H., Holtz, J., et al. (2003). Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. Journal of the American College of Cardiology, 42(12), 2073–2080.
Thijssen, D. H., Vos, J. B., Verseyden, C., van Zonneveld, A. J., Smits, P., Sweep, F. C., et al. (2006). Haematopoietic stem cells and endothelial progenitor cells in healthy men: Effect of aging and training. Aging Cell, 5(6), 495–503.
Hoetzer, G. L., Van Guilder, G. P., Irmiger, H., Keith, R. S., Stauffer, B. L., & Desouza, C. A. (2007). Aging, exercise and endothelial progenitor cell clonogenic and migratory capacity in men. Journal of Applied Physiology, 102, 847–852.
Mieno, S., Boodhwani, M., Clements, R. T., Ramlawi, B., Sodha, N. R., Li, J., et al. (2006). Aging is associated with an impaired coronary microvascular response to vascular endothelial growth factor in patients. Journal of Thoracic and Cardiovascular Surgery, 132(6), 1348–1355.
Zhang, W., Zhang, G., Jin, H., & Hu, R. (2006). Characteristics of bone marrow-derived endothelial progenitor cells in aged mice. Biochemical and Biophysical Research Communications, 348(3), 1018–1023.
Heiss, C., Keymel, S., Niesler, U., Ziemann, J., Kelm, M., & Kalka, C. (2005). Impaired progenitor cell activity in age-related endothelial dysfunction. Journal of the American College of Cardiology, 45(9), 1441–1448.
Hoetzer, G. L., MacEneaney, O. J., Irmiger, H. M., Keith, R., Van Guilder, G. P., Stauffer, B. L., et al. (2007). Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. American Journal of Cardiology, 99(1), 46–48.
Edelberg, J. M., Tang, L., Hattori, K., Lyden, D., & Rafii, S. (2002). Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circulation Research, 90(10), E89–E93.
Klibansky, D. A., Chin, A., Duignan, I. J., & Edelberg, J. M. (2006). Synergistic targeting with bone marrow-derived cells and PDGF improves diabetic vascular function. American Journal of Physiology Heart and Circulatory Physiology, 290(4), H1387–H1392.
Swift, M. E., Kleinman, H. K., & DiPietro, L. A. (1999). Impaired wound repair and delayed angiogenesis in aged mice. Laboratory Investigation, 79(12), 1479–1487.
Rivard, A., Fabre, J., Silver, M., Chen, D., Murohara, T., Kearney, M., et al. (1999). Aged-dependent impairment of angiogenesis. Circulation, 99, 111–120.
Reed, M. J., Corsa, A. C., Kudravi, S. A., McCormick, R. S., & Arthur, W. T. (2000). A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. Journal of Cellular Biochemistry, 77(1), 116–126.
Xia, Y. P., Zhao, Y., Tyrone, J. W., Chen, A., & Mustoe, T. A. (2001). Differential activation of migration by hypoxia in keratinocytes isolated from donors of increasing age: Implication for chronic wounds in the elderly. Journal of Investigative Dermatology, 116(1), 50–56.
Koike, T., Vernon, R. B., Gooden, M. D., Sadoun, E., & Reed, M. J. (2003). Inhibited angiogenesis in aging: A role for TIMP-2. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 58(9), B798–B805.
Rauscher, F. M., Goldschmidt-Clermont, P. J., Davis, B. H., Wang, T., Gregg, D., Ramaswami, P., et al. (2003). Aging, progenitor cell exhaustion, and atherosclerosis. Circulation, 108(4), 457–463.
Pallante, B. A., Duignan, I., Okin, D., Chin, A., Bressan, M. C., Mikawa, T., et al. (2007). Bone marrow Oct3/4+ cells differentiate into cardiac myocytes via age-dependent paracrine mechanisms. Circulation Research, 100(1), e1–e11.
Edelberg, J. M., Lee, S. H., Kaur, M., Tang, L., Feirt, N. M., McCabe, S., et al. (2002). Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: Feasibility of restoring impaired angiogenic capacity in the aging heart. Circulation, 105(5), 608–613.
Xaymardan, M., Tang, L., Zagreda, L., Pallante, B., Zheng, J., Chazen, J. L., et al. (2004). Platelet-derived growth factor-AB promotes the generation of adult bone marrow-derived cardiac myocytes. Circulation Research, 94(5), E39–E45.
Rosenzweig, A. (2006). Cardiac cell therapy-mixed results from mixed cells. New England Journal of Medicine, 355(12), 1274–1277.
Shantsila, E., Watson, T., & Lip, G. Y. (2007). Endothelial progenitor cells in cardiovascular disorders. Journal of the American College of Cardiology, 49(7), 741–752.
Badorff, C., Brandes, R. P., Popp, R., Rupp, S., Urbich, C., Aicher, A., et al. (2003). Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation, 107(7), 1024–1032.
Alvarez-Dolado, M., Pardal, R., Garcia-Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., et al. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature, 425(6961), 968–973.
Aicher, A., Zeiher, A. M., & Dimmeler, S. (2005). Mobilizing endothelial progenitor cells. Hypertension, 45(3), 321–325.
Wollert, K. C., Meyer, G. P., Lotz, J., Ringes-Lichtenberg, S., Lippolt, P., Breidenbach, C., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet, 364(9429), 141–148.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reed, M.J., Karres, N., Eyman, D. et al. Endothelial Precursor Cells. Stem Cell Rev 3, 218–225 (2007). https://doi.org/10.1007/s12015-007-0007-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-007-0007-5